Oric Pharmaceuticals | 10-Q:季度报表
05/06 16:28 (美东)
Oric Pharmaceuticals | 8-K:ORIC 制药公布2024年第一季度财务业绩和运营最新情况
05/06 16:15 (美东)
Oric Pharmaceuticals | ARS:年度报告
04/24 16:21 (美东)
Oric Pharmaceuticals | DEFA14A:其他
04/24 16:16 (美东)
Oric Pharmaceuticals | DEF 14A:股东委托书决议
04/24 16:09 (美东)
Oric Pharmaceuticals | S-8:员工福利计划证券登记
03/29 16:53 (美东)
Oric Pharmaceuticals | 8-K:重大事件
03/29 16:20 (美东)
Oric Pharmaceuticals | S-3ASR:“知名成熟发行人”证券注册声明
03/11 17:33 (美东)
Oric Pharmaceuticals | 10-K:年度报表
03/11 16:25 (美东)
Oric Pharmaceuticals | 8-K:ORIC Pharmicals公布2023年第四季度和全年财务业绩和运营最新情况
03/11 16:13 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(7.562%),Abigail P. Johnson(7.562%)
03/11 08:22 (美东)
Oric Pharmaceuticals | 4:持股变动声明-高管 Chacko Jacob
03/08 16:24 (美东)
Oric Pharmaceuticals | 144:拟议出售证券
03/06 16:33 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(8.9%),Oleg Nodelman(8.9%)等
02/14 18:24 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Alkeon Capital Management, LLC(6.6%),Panayotis D. Sparaggis(6.6%)
02/13 18:46 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Prosight Management, LP(2.9%),Prosight Partners, LLC(2.9%)等
02/13 09:29 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(12.835%),Abigail P. Johnson(12.835%)
02/09 09:35 (美东)
Oric Pharmaceuticals | 4:持股变动声明-高管 Chacko Jacob
02/08 20:06 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.5%)
02/07 17:14 (美东)
Oric Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Millennium Management LLC(0.0%),Millennium Group Management LLC(0.0%)等
02/06 16:18 (美东)
暂无数据
暂无数据